| Recruiting | A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Metastatic Castration-Resistant Prostate Cancer | Phase 2 | 2026-02-22 |
| Withdrawn | Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patient Anemia Associated With Chronic Kidney Disease | Phase 3 | 2022-05-23 |
| Completed | A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receivin Chemotherapy Induced Anemia | Phase 3 | 2022-03-16 |
| Terminated | Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambu Duchenne Muscular Dystrophy | Phase 3 | 2021-03-03 |
| Terminated | Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 3 | 2020-09-30 |
| Terminated | Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duch Duchenne Muscular Dystrophy | Phase 3 | 2020-08-10 |
| Completed | Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodial Anemia Associated With End Stage Renal Disease | Phase 3 | 2020-07-22 |
| Terminated | Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 COVID-19 | Phase 2 | 2020-06-20 |
| Completed | Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as I Anemia Associated With End Stage Renal Disease (ESRD) | Phase 3 | 2020-05-26 |
| Completed | Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia Chemotherapy Induced Anemia | Phase 2 | 2019-08-20 |
| Terminated | Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosi Idiopathic Pulmonary Fibrosis | Phase 3 | 2019-06-18 |
| Completed | Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysi CKD Anemia in Dialysis Participants | Phase 4 | 2019-06-11 |
| Completed | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy ( Pancreatic Cancer Non-resectable | Phase 3 | 2019-05-10 |
| Completed | Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrom Anemia, Myelodysplastic Syndrome | Phase 2 / Phase 3 | 2018-06-06 |
| Terminated | Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Synd Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts), Anemia | Phase 3 | 2018-01-29 |
| Terminated | Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2016-01-04 |
| Completed | FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis Anemia | Phase 3 | 2015-12-01 |
| Completed | FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Anemia | Phase 3 | 2015-12-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD o CKD Anemia in Stable Dialysis Patients | Phase 3 | 2015-01-15 |
| Completed | A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unre Pancreatic Cancer (Unresectable) | Phase 1 / Phase 2 | 2014-07-31 |
| Completed | Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD Anemia in Incident Dialysis Patients | Phase 3 | 2014-02-11 |
| Completed | Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis ( Idiopathic Pulmonary Fibrosis | Phase 2 | 2013-07-30 |
| Completed | A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receivin CKD Anemia | Phase 3 | 2012-11-05 |
| Completed | Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis a Chronic Kidney Disease, End Stage Renal Disease, Anemia | Phase 2 | 2012-05-18 |
| Completed | Study of FG-4592 in Subjects With Chronic Kidney Disease in China Anemia in Chronic Kidney Disease | Phase 2 | 2011-12-01 |
| Completed | Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China Anemia in End Stage Renal Disease | Phase 2 | 2011-09-01 |
| Completed | Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis Dialysis, Anemia | Phase 2 | 2011-07-21 |
| Completed | Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2011-03-01 |
| Completed | Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia Chronic Kidney Disease, Anemia | Phase 2 | 2010-10-29 |
| Terminated | A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection Liver Fibrosis Due to Chronic Hepatitis B Infection | Phase 2 | 2010-08-01 |
| Completed | Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis End Stage Renal Disease, Anemia | Phase 2 | 2010-05-17 |
| Completed | Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects Healthy Adult Subjects | Phase 1 | 2010-03-01 |
| Terminated | Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Th Type 2 Diabetes Mellitus, Diabetic Nephropathy, Diabetic Kidney Disease | Phase 2 | 2009-02-01 |
| Completed | A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subje Locally Advanced or Metastatic Pancreatic Cancer | Phase 1 | 2008-12-01 |
| Terminated | Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS Focal Segmental Glomerulosclerosis | Phase 1 | 2008-04-01 |
| Completed | Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy Diabetes Mellitus, Diabetic Nephropathy | Phase 1 | 2008-03-01 |
| Completed | Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis Chronic Kidney Disease, Anemia | Phase 2 | 2006-11-01 |
| Completed | A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis Renal Anemia | Phase 2 | 2005-12-01 |
| Completed | Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus Diabetes Mellitus | Phase 1 | 2005-01-01 |
| Completed | Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 1 | 2003-12-08 |